Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07555002

Prospective User Study and Multicenter Validation of Multimodal Medical Imaging Large Models

This study aims to evaluate the diagnostic performance and clinical utility of a multimodal medical imaging large model in identifying common systemic diseases. Through a retrospective reader study involving multiple centers, the research will compare the diagnostic accuracy, sensitivity, and specificity of radiologists with and without AI assistance. The goal is to validate the model's robustness and its impact on the diagnostic efficiency of clinicians across diverse healthcare settings.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The Third Affiliated Hospital of Southern Medical University

Guangzhou, Guangdong, 510630, China

Location status: Recruiting

Location contact

Tao Li, MD

CONTACT

[email protected]

+86-15527360835

About this study

Background: Multimodal large models have shown significant potential in medical imaging. However, their performance and impact on clinical workflows across multiple centers require rigorous validation.

Objective: To assess the diagnostic performance of a multimodal large model and investigate whether AI assistance can improve the diagnostic accuracy and efficiency of radiologists with varying levels of experience.

Methodology: This research is designed as a multicenter, retrospective comparative reader study. A large-scale, diverse dataset of medical images (including CT and MRI) will be curated from the participating institutions. A group of licensed radiologists will perform diagnostic tasks in two separate sessions: a standalone session (without AI assistance) and an AI-assisted session, with a suitable washout period between sessions.

Data Analysis: The clinical "ground truth" will be established by expert consensus or histological results. The study will compare the Area Under the Receiver Operating Characteristic Curve (AUC), sensitivity, and specificity between the standalone and AI-assisted modes. Additionally, the reading time per case will be recorded to evaluate diagnostic efficiency.

Ethics: This study uses retrospective, anonymized data and does not alter the clinical management or treatment of patients.

The multimodal large model was developed and pre-trained using a massive dataset of approximately 1,000,000 medical imaging cases. This study focus on the multicenter clinical validation using an independent test cohort of 1,000 cases.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who underwent systemic medical imaging examinations (e.g., CT or MRI) at participating centers for common systemic diseases.
  • Imaging data must have confirmed clinical reference standards, expert consensus, or pathological diagnosis.
  • Availability of complete DICOM format images with standard acquisition protocols.

Exclusion criteria

  • Poor image quality (e.g., severe motion or metal artifacts) that precludes definitive diagnosis.
  • Cases with incomplete clinical or pathological reference standards.
  • Corrupted image files or duplicate cases.

Treatment and study plan

Standalone Radiologist Interpretation

Other

Radiologists interpret the medical images independently without any assistance from the AI model to establish a baseline performance.

AI-assisted Radiologist Interpretation

Other

Radiologists interpret the same set of medical images with the assistance of the multimodal medical imaging large model to evaluate the improvement in diagnostic performance.

Primary outcomes

  1. Area Under the Receiver Operating Characteristic Curve (AUC)

    Time frame: Through study completion, approximately 12 months.

    Evaluation of diagnostic accuracy using AUC to compare standalone radiologist performance versus AI-assisted performance.

Secondary outcomes

  1. Mean Reading and Reporting Time per Case

    Time frame: Through study completion, approximately 12 months.

    Assessment of diagnostic efficiency by recording the time (in seconds) taken by radiologists to complete the diagnosis and generate reports, with and without AI assistance.

  2. Clinical Report Quality and Semantic Accuracy Score

    Time frame: Through study completion, approximately 12 months.

    The quality of AI-generated reports will be evaluated by senior experts using a 5-point Likert scale, focusing on semantic accuracy, clinical relevance, and completeness of the descriptions. The scale ranges from 1 to 5, where 1 indicates "poor quality" and 5 indicates "excellent quality." Higher scores represent better report quality and higher semantic accuracy.

  3. Sensitivity and Specificity

    Time frame: Through study completion, approximately 12 months.

    To calculate and compare the sensitivity and specificity of radiologists' diagnostic decisions in both standalone and AI-assisted sessions.

Study contacts

Contact information is provided by the study sponsor or research team.

Tao Li, MD

CONTACT

[email protected]

+86-15527360835

Sponsors and collaborators

Lead sponsor

The Third Affiliated Hospital of Southern Medical University

Other Gov

Registry information

Official study title

Prospective User Study and Multicenter Validation of Multimodal Medical Imaging Large Models in the Diagnosis of Common Systemic Diseases

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 28, 2026
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.